NASDAQ : IVVD
Invivyd, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.5817 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Invivyd, Inc. (IVVD) reported revenue of 58.37M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 58.37M | 53.43M | 25.38M | |||
| Cost of Revenue | 4.53M | 3.75M | 1.62M | |||
| Gross Profit | 53.83M | 49.68M | 23.77M | |||
| Selling, General & Admin | 88.17M | 66.93M | 63.39M | 49.12M | 47.04M | 36.52M |
| Research & Development | 78.19M | 38.31M | 137.25M | 158.66M | 179.21M | 182.89M |
| Operating Expenses | 166.37M | 105.24M | 200.64M | 207.78M | 226.26M | 219.41M |
| Operating Income | -112.53M | -55.56M | -176.88M | -207.78M | -226.26M | -219.41M |
| Interest & Investment Income | 5.32M | 3.11M | 7.22M | 7.36M | 3.90M | 1.70M |
| Other Non Operating Income (Expenses) | -119.00K | -36.00K | -265.00K | -47.00K | -17.36M | -152.00K |
| EBT Excluding Unusual Items | -107.33M | -52.49M | -169.93M | -200.47M | -239.72M | -217.86M |
| Gain (Loss) on Sale of Investments | 6.80M | 2.80M | -1.43M | |||
| Pretax Income | -107.33M | -52.49M | -169.93M | -198.64M | -241.32M | -226.79M |
| Net Income | -107.33M | -52.49M | -169.93M | -198.64M | -241.32M | -226.79M |
| Net Income to Common | -107.33M | -52.49M | -169.93M | -198.64M | -241.32M | -226.79M |
| Shares Outstanding (Basic) | 269.78M | 172.21M | 118.56M | 109.53M | 108.27M | 42.62M |
| Shares Outstanding (Diluted) | 269.78M | 172.21M | 118.56M | 109.53M | 108.27M | 42.62M |
| EPS (Basic) | -0.40 | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 |
| EPS (Diluted) | -0.40 | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 |
| Free Cash Flow | -109.66M | -58.29M | -170.63M | -173.78M | -221.69M | -184.82M |
| Free Cash Flow Per Share | -0.41 | -0.34 | -1.44 | -1.59 | -2.05 | -4.34 |
| Gross Margin | 92.23% | 92.99% | 93.63% | |||
| Operating Margin | -192.81% | -103.99% | -696.80% | |||
| Profit Margin | -183.90% | -98.25% | -669.42% | |||
| Free Cash Flow Margin | -187.88% | -109.10% | -672.20% | |||
| EBITDA | -111.89M | -54.80M | -175.41M | -207.30M | -226.22M | -219.41M |
| EBITDA Margin | -191.70% | -102.58% | ||||
| D&A For EBITDA | 646.00K | 755.00K | 1.47M | 480.00K | 41.00K | 1.00K |
| EBIT | -112.53M | -55.56M | -176.88M | -207.78M | -226.26M | -219.41M |
| EBIT Margin | -192.81% | -103.99% | ||||
| Revenue as Reported | 58.37M | 53.43M | 25.38M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 160.08M | 226.69M | 69.35M | 200.64M | 92.08M | 542.22M |
| Short-Term Investments | 279.92M | 49.19M | ||||
| Cash & Short-Term Investments | 160.08M | 226.69M | 69.35M | 200.64M | 371.99M | 591.42M |
| Accounts Receivable | 11.22M | 13.92M | 10.91M | |||
| Other Receivables | 461.00K | 676.00K | 263.00K | 933.00K | 377.00K | 229.00K |
| Receivables | 11.68M | 14.60M | 11.17M | 933.00K | 377.00K | 229.00K |
| Inventory | 310.00K | 263.00K | ||||
| Prepaid Expenses | 1.24M | 1.02M | 1.17M | 1.77M | 2.39M | 3.19M |
| Other Current Assets | 8.80M | 4.90M | 18.99M | 21.54M | 2.16M | 21.87M |
| Total Current Assets | 182.11M | 247.47M | 100.68M | 224.88M | 376.92M | 616.71M |
| Property, Plant & Equipment | 10.25M | 3.81M | 2.89M | 4.12M | 6.06M | 83.00K |
| Other Long-Term Assets | 26.52M | 25.61M | 25.94M | 175.00K | 191.00K | 3.30M |
| Total Assets | 218.88M | 276.88M | 129.51M | 229.18M | 383.17M | 620.09M |
| Accounts Payable | 9.49M | 13.74M | 10.45M | 7.95M | 1.52M | 5.78M |
| Accrued Expenses | 19.86M | 19.05M | 50.20M | 40.86M | 21.91M | 56.28M |
| Current Portion of Leases | 1.62M | 1.31M | 1.30M | 1.44M | 1.56M | |
| Other Current Liabilities | 71.00K | 52.00K | 27.00K | 35.00K | 44.00K | |
| Total Current Liabilities | 31.03M | 34.16M | 61.98M | 50.29M | 25.03M | 62.06M |
| Long-Term Leases | 6.78M | 1.18M | 722.00K | 2.17M | ||
| Other Long-Term Liabilities | 700.00K | 1.00K | 12.00K | |||
| Total Liabilities | 37.80M | 35.34M | 61.98M | 51.71M | 27.20M | 62.07M |
| Common Stock | 29.00K | 28.00K | 12.00K | 11.00K | 11.00K | 11.00K |
| Additional Paid-In Capital | 1.22B | 1.20B | 969.53M | 909.54M | 889.66M | 850.12M |
| Retained Earnings | -1.04B | -954.48M | -901.99M | -732.07M | -533.43M | -292.11M |
| Comprehensive Income & Other | -35.00K | -41.00K | -5.00K | -13.00K | -272.00K | -8.00K |
| Total Common Equity | 181.08M | 241.54M | 67.54M | 177.47M | 355.97M | 558.02M |
| Shareholders' Equity | 181.08M | 241.54M | 67.54M | 177.47M | 355.97M | 558.02M |
| Total Liabilities & Equity | 218.88M | 276.88M | 129.51M | 229.18M | 383.17M | 620.09M |
| Total Debt | 8.39M | 2.49M | 1.30M | 2.17M | 3.72M | |
| Net Cash (Debt) | 151.69M | 224.19M | 68.05M | 198.48M | 368.27M | 591.42M |
| Net Cash Per Share | 0.56 | 1.30 | 0.57 | 1.81 | 3.40 | 13.88 |
| Filing Date Shares Outstanding | 294.76M | 282.59M | 119.96M | 119.22M | 109.19M | 109.68M |
| Total Common Shares Outstanding | 294.76M | 281.99M | 119.84M | 110.16M | 109.04M | 110.78M |
| Working Capital | 151.08M | 213.30M | 38.70M | 174.59M | 351.89M | 554.65M |
| Book Value Per Share | 0.61 | 0.86 | 0.56 | 1.61 | 3.26 | 5.04 |
| Tangible Book Value | 181.08M | 241.54M | 67.54M | 177.47M | 355.97M | 558.02M |
| Tangible Book Value Per Share | 0.61 | 0.86 | 0.56 | 1.61 | 3.26 | 5.04 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -107.33M | -52.49M | -169.93M | -198.64M | -241.32M | -226.79M |
| Depreciation & Amortization | 2.02M | 2.11M | 3.11M | 2.03M | 462.00K | 1.00K |
| Loss (Gain) From Sale of Investments | -1.12M | -2.02M | 1.43M | |||
| Stock-Based Compensation | 11.23M | 11.64M | 19.79M | 18.68M | 21.65M | 17.76M |
| Other Operating Activities | 214.00K | 298.00K | 17.37M | 66.00K | ||
| Change in Accounts Receivable | -2.73M | -3.34M | -10.91M | |||
| Change in Inventory | -194.00K | -373.00K | -24.89M | |||
| Change in Accounts Payable | -8.71M | 3.21M | 2.42M | 6.47M | -4.30M | -2.37M |
| Change in Other Net Operating Assets | -2.91M | -19.20M | 9.90M | -583.00K | -11.83M | 25.16M |
| Operating Cash Flow | -108.42M | -58.13M | -170.49M | -173.16M | -219.99M | -184.74M |
| Capital Expenditures | -1.24M | -155.00K | -140.00K | -615.00K | -1.71M | -84.00K |
| Investment in Securities | 281.30M | -228.96M | -50.63M | |||
| Investing Cash Flow | -1.24M | -155.00K | -140.00K | 280.68M | -230.67M | -50.71M |
| Issuance of Common Stock | 236.17M | 216.60M | 39.93M | 1.20M | 510.00K | 330.90M |
| Repurchase of Common Stock | -1.00K | -4.00K | ||||
| Other Financing Activities | -1.33M | -969.00K | -597.00K | -149.00K | -3.38M | |
| Financing Cash Flow | 234.83M | 215.63M | 39.33M | 1.04M | 506.00K | 662.68M |
| Foreign Exchange Rate Adjustments | 8.00K | |||||
| Net Cash Flow | 125.17M | 157.34M | -131.29M | 108.56M | -450.15M | 427.24M |
| Free Cash Flow | -109.66M | -58.29M | -170.63M | -173.78M | -221.69M | -184.82M |
| Free Cash Flow Margin | -187.88% | -109.10% | -672.20% | |||
| Free Cash Flow Per Share | -0.41 | -0.34 | -1.44 | -1.59 | -2.05 | -4.34 |
| Levered Free Cash Flow | -69.95M | -38.40M | -83.05M | -103.70M | -139.23M | -93.29M |
| Unlevered Free Cash Flow | -69.95M | -38.40M | -83.05M | -103.70M | -139.23M | -93.29M |
| Change in Working Capital | -14.55M | -19.69M | -23.47M | 5.89M | -16.13M | 22.79M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 168.16M | 684.49M | 53.00M | 433.85M | 163.47M | 807.69M |
| Enterprise Value | 16.47M | 602.20M | -52.23M | 171.53M | -253.69M | 141.37M |
| Last Close Price | 0.58 | 2.47 | 0.44 | 3.94 | 1.50 | 7.26 |
| Forward PE | 11.98 | |||||
| PS Ratio | 2.88 | 12.81 | 2.09 | |||
| PB Ratio | 0.95 | 2.83 | 0.79 | 2.44 | 0.46 | 1.45 |
| P/TBV Ratio | 0.93 | 2.83 | 0.79 | 2.44 | 0.46 | 1.45 |
| EV/Sales Ratio | 0.28 | 11.27 | ||||
| Debt / Equity Ratio | 0.05 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.84 | -0.93 | -1.01 | -1.12 | -1.03 | -1.06 |
| Net Debt / EBITDA Ratio | 1.36 | 4.09 | 0.39 | 0.96 | 1.63 | 2.70 |
| Net Debt / FCF Ratio | 1.38 | 3.85 | 0.40 | 1.14 | 1.66 | 3.20 |
| Asset Turnover | 0.38 | 0.26 | 0.14 | |||
| Quick Ratio | 5.54 | 7.06 | 1.30 | 4.01 | 14.88 | 9.53 |
| Current Ratio | 5.87 | 7.24 | 1.62 | 4.47 | 15.06 | 9.94 |
| Return on Equity (ROE) | -95.89% | -33.97% | -138.71% | -74.48% | -52.80% | -68.48% |
| Return on Assets (ROA) | -45.67% | -17.09% | -61.64% | -42.42% | -28.19% | -37.19% |
| Return on Capital Employed (ROCE) | -59.90% | -22.90% | -261.90% | -116.20% | -63.20% | -39.30% |
| Earnings Yield | -69.74% | -7.67% | -320.60% | -45.79% | -147.62% | -28.08% |
| FCF Yield | -65.21% | -8.52% | -321.93% | -40.05% | -135.61% | -22.88% |
| Buyback Yield / Dilution | -125.22% | -45.26% | -8.24% | -1.16% | -154.02% | -1,081.14% |